Cita APA (7a ed.)

S, L., Y, H., J, Y., Z, Z., X, L., N, F., . . . Q, H. (2021). Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in vivo and in vitro. Dove Medical Press.

Cita Chicago Style (17a ed.)

S, Li, Hui Y, Yuan J, Zhang Z, Li X, Fang N, Lin M, y Hou Q. Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in Vivo and in Vitro. Dove Medical Press, 2021.

Cita MLA (8a ed.)

S, Li, et al. Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in Vivo and in Vitro. Dove Medical Press, 2021.